Colossal Biosciences is pursuing the ambitious goal of reviving extinct species, such as the woolly mammoth, with over $400 million raised to fund these initiatives. CEO Ben Lamm emphasizes that the true value lies not only in de-extinction itself but also in the technological advancements made during the process. Drawing parallels to innovations from the space race, he highlights potential applications in diverse fields like healthcare, longevity, and environmental solutions. To resurrect the woolly mammoth, the startup utilizes the Asian elephant's DNA alongside advanced AI techniques to analyze well-preserved mammoth DNA samples.
There's so much that goes into humans landing on the moon. Well, the same thing goes for de-extinction - you have to build computational biology, cellular engineering, stem cell reprogramming, genetic engineering, monoclonal screening, and embryology.
The startup is exploring spinning out technologies in areas like longevity, human healthcare, and plastic degradation.
Collection
[
|
...
]